HomeTCRT • NASDAQ
add
Alaunos Therapeutics Inc
Previous close
$3.48
Day range
$3.03 - $3.48
Year range
$1.31 - $6.20
Market cap
7.21M USD
Avg Volume
63.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 718.00K | -28.70% |
Net income | -1.16M | -2.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.19M | -3.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.94M | 15.15% |
Total assets | 3.72M | 4.90% |
Total liabilities | 921.00K | 11.50% |
Total equity | 2.80M | — |
Shares outstanding | 2.23M | — |
Price to book | 2.74 | — |
Return on assets | -70.16% | — |
Return on capital | -91.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.16M | -2.84% |
Cash from operations | -844.00K | -8.07% |
Cash from investing | -97.00K | — |
Cash from financing | 0.00 | — |
Net change in cash | -941.00K | -20.49% |
Free cash flow | -578.88K | -55.72% |
About
Founded
1998
Website
Employees
1
